The NxStage® cartridge is used with NxStagecyclers and provides patient flexibility for more frequent, nocturnal, or intermittent kidney replacement therapy at home.
NxStage Cartridges offer:
Easy set-up
Flexible therapy options including more frequent and nocturnal
Effective removal of small and middle molecular toxins with simultaneous retention of valuable proteins and achievement of high clearance1.
NxStage offers a selection of cartridge configurations used for hemodialysis treatments performed in the home, during the day, or overnight while the patient sleeps.
NxStage Cartridge Express (CAR-170 and CAR-172)
Cartridge Express products are single use, gamma sterilized, and include an integrated dialyzer.
For patients requiring anticoagulation infusions while performing their treatments at home, the CAR-172 NxStage includes a separate, dedicated line that can be connected to an anticoagulation infusion pump.1
NxStage Standard Cartridge (CAR-124)
The NxStage cartridge CAR-124 offers additional flexible therapy options and can be used with alternate dialyzers to meet your patient’s clinical needs.
For more information on the Cartridges, call NxStage at 1-866-NXSTAGE (697-8243) or fill out the form to speak with an expert.
Ease of use extends to the steps to begin a treatment: Insert a single-use cartridge into the cycler, spike a bag of saline, and press the start priming button on the touch screen. Pressing the ‘Guide Me’ button displays step-by-step illustrated instructions to assist in a particular task.
A state of the art telehealth platform for the collection and delivery of home hemodialysis treatment and patient medical information.
Risks and Responsibilities
Patients should review the following information carefully and discuss it with their doctors to decide whether home hemodialysis with NxStage systems is right for them.
Users should weigh the risks and benefits of performing home hemodialysis with NxStage systems.
Medical staff will not be present to respond to health emergencies that might happen during home treatments.
Users and their care partners will be responsible for all aspects of their hemodialysis treatments from start to finish.
Users may not experience the reported benefits of home, more frequent or nocturnal hemodialysis with the NxStage systems.
The NxStage systems require a prescription for use
Certain forms of home hemodialysis have additional risks.
If a doctor prescribes more frequent home hemodialysis, vascular access is exposed to more frequent use which may lead to access related complications, including infection of the site. Doctors should evaluate the medical necessity of more frequent treatments and discuss the risks and benefits of more frequent therapy with users.
If a doctor prescribes “solo/independent” home hemodialysis without a care partner during waking hours, risks of significant injury or death increase because no one is present to help users respond to health emergencies. If users experience needles coming out, blood loss, or very low blood pressure during solo home hemodialysis, they may lose consciousness or become physically unable to correct the health emergency. Users will need additional ancillary devices and training to perform solo home hemodialysis.
If a doctor prescribes “nocturnal” home hemodialysis at night while the user and a care partner are sleeping, risks increase due to the length of treatment time and because therapy is performed while users and their care partners are sleeping. These risks include, among other things, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow or increased treatment time or both, and delayed response to alarms when waking from sleep.
References:
Leypoldt JK, Kamerath CD, Gilson JF, Friederichs G. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates. ASAIO J. 2006;52(4):404–9.
